Literature DB >> 5667302

An additional pseudocholinesterase phenotype occurring in suxamethonium apnoea.

M Whittaker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5667302     DOI： 10.1093/bja/40.8.579

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  5 in total

1.  The use of serum cholinesterase in succinylcholine apnoea.

Authors:  K L Scholler; H W Goedde; H G Benkmann
Journal:  Can Anaesth Soc J       Date:  1977-05

2.  [Apnea due to succinyldicholine: study of a French-Canadian population].

Authors:  B Hazel; D Monier; L Trempe; M Beauchemin; Y Rondeau
Journal:  Can Anaesth Soc J       Date:  1970-01

3.  Hydrolysis of suxamethonium by different types of plasma.

Authors:  F Hobbiger; A W Peck
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

4.  [Clinical significance of blood cholinesterase activity in neurologic patients and persons working with organic phosphates].

Authors:  M Sercl; V Kyral; J Kovarík; A Jakl; J Tulach; J Jindrichová
Journal:  Int Arch Arbeitsmed       Date:  1970

5.  Suxamethonium-the development of a modern drug from 1906 to the present day.

Authors:  H R Dorkins
Journal:  Med Hist       Date:  1982-04       Impact factor: 1.419
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.